Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji Luo

Showing results (361-370 of 416) with videos related to

Pageof 42
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinaseJi Luo, Cassandra L Sobkiw, Nicole M Logsdon, et al.
Methods (San Diego, Calif.)|April 16, 2018
Microbial expression systems for membrane proteinsMarvin V Dilworth, Mathilde S Piel, Kim E Bettaney, et al.
Nature Communications|May 16, 2022
Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editingSanju Sinha, Karina Barbosa, Kuoyuan Cheng, et al.
Virology Journal|March 20, 2022
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infectionsJi Luo, Alexandra Brakel, Andor Krizsan, et al.
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Nature Communications|November 12, 2021
A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editingSanju Sinha, Karina Barbosa, Kuoyuan Cheng, et al.
Oncotarget|September 24, 2014
Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cellsToshifumi Hara, Matthew F Jones, Murugan Subramanian, et al.
The Journal of Biological Chemistry|February 8, 2025
Biochemical and biophysical characterization of inositol-tetrakisphosphate 1-kinase inhibitorsMartin Y Ng, Huanchen Wang, Haibo Zhang, et al.
Science (New York, N.Y.)|May 26, 2012
Recurrent hemizygous deletions in cancers may optimize proliferative potentialNicole L Solimini, Qikai Xu, Craig H Mermel, et al.
Plos Genetics|June 21, 2022
Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competenceVanesa C Sanchez, Howard H Yang, Alayna Craig-Lucas, et al.
Pageof 42

Showing results (361-370 of 416) with videos related to

Sort By:
Pageof 42
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinaseJi Luo, Cassandra L Sobkiw, Nicole M Logsdon, et al.
Methods (San Diego, Calif.)|April 16, 2018
Microbial expression systems for membrane proteinsMarvin V Dilworth, Mathilde S Piel, Kim E Bettaney, et al.
Nature Communications|May 16, 2022
Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editingSanju Sinha, Karina Barbosa, Kuoyuan Cheng, et al.
Virology Journal|March 20, 2022
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infectionsJi Luo, Alexandra Brakel, Andor Krizsan, et al.
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Nature Communications|November 12, 2021
A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editingSanju Sinha, Karina Barbosa, Kuoyuan Cheng, et al.
Oncotarget|September 24, 2014
Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cellsToshifumi Hara, Matthew F Jones, Murugan Subramanian, et al.
The Journal of Biological Chemistry|February 8, 2025
Biochemical and biophysical characterization of inositol-tetrakisphosphate 1-kinase inhibitorsMartin Y Ng, Huanchen Wang, Haibo Zhang, et al.
Science (New York, N.Y.)|May 26, 2012
Recurrent hemizygous deletions in cancers may optimize proliferative potentialNicole L Solimini, Qikai Xu, Craig H Mermel, et al.
Plos Genetics|June 21, 2022
Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competenceVanesa C Sanchez, Howard H Yang, Alayna Craig-Lucas, et al.
Pageof 42